Q3 2016 GI Dynamics, Inc Earnings Conference Call
Wednesday, November 9, 2016 4:30 p.m. ET Webcast PresentationWeight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
The duodenal-jejunal bypass liner (DJBL) is an endoscopic treatment for patients with type 2 diabetes mellitus (T2DM) and (morbid) obesity. The aim of the current study was to determine its efficacy and safety profile.Amer Soc of Metabolic and Bariatric Surgeons (ASMBS)/The Obesity Society (TOS)
New Orleans, LAUnited European Gastro Week (UEGW)
Vienna, AustriaSafety- and efficacy-outcomes of the duodenal-jejunal bypass liner (DJBL) registry in obese patients with type 2 diabetes
Safety- and efficacy-outcomes of the duodenal-jejunal bypass liner (DJBL) registry in obese patients with type 2 diabetesBeneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Implantation of a duodenal-jejunal endoluminal bypass liner (DJBL) has shown to induce weight loss and to improve metabolic parameters. DJBL is a reversible endoduodenal sleeve mimicking duodenal bypass while lacking risks and limitations of bariatric surgery. Effects...![Product Overview](https://morphicmedical.com/wp-content/uploads/2015/04/video-thumb2.png)